Acrylamide catalytically inhibits topoisomerase II in V79 cells

Toxicology in Vitro

Volumn 24, Issue 3, 2010, Pages 830-834

  Sciandrello, Giulia ^a   Mauro, Maurizio ^a   Caradonna, Fabio ^a   Catanzaro, Irene ^a   Saverini, Marghereth ^a   Barbata, Giusi ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Acrylamide; Topoisomerase II; V79 cells

Indexed keywords

ACRYLAMIDE; DNA TOPOISOMERASE (ATP HYDROLYSING); KINETOPLAST DNA;

ANIMAL CELL; ARTICLE; CATALYSIS; CHINESE HAMSTER; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; NONHUMAN;

ACRYLAMIDE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; COLONY-FORMING UNITS ASSAY; CRICETINAE; DNA CLEAVAGE; DNA TOPOISOMERASES, TYPE II; DNA, KINETOPLAST; ETOPOSIDE; NUCLEIC ACID SYNTHESIS INHIBITORS;

CRICETULUS GRISEUS;

EID: 77649338945     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.12.010     Document Type: Article

References (27)

1. Besaratinia A., and Pfeifer G.P. DNA adduction and mutagenic properties of acrylamide. Mutat. Res. 580 (2005) 31-40
2. Besaratinia A., and Pfeifer G.P. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 28 (2007) 519-528
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Carere A. Genotoxicity and carcinogenicity of acrylamide: a critical review. Ann Ist Super Sanita. 42 (2006) 144-155
5. 1. Proc. Natl. Acad. Sci. USA 85 (1988) 5769-5773
6. Fortune J.M., and Osheroff N. Merbarone inhibits the catalytic activity of human topoisomerase IIa by blocking DNA cleavage. J. Biol. Chem. 273 (1998) 17643-17650
7. Fortune J.M., and Osheroff N. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog. Nucleic Acid Res. Mol. Biol. 64 (2000) 221-253
8. Friedman M. Chemistry, biochemistry, and safety of acrylamide. A review. J. Agric. Food Chem. 57 (2003) 4504-4526
9. Ghanayem B.I., McDaniel L.P., Churchwell M.I., Twaddle N.C., Snyder R., Timothy R., Fennell T.R., Daniel R., and Doerge D.R. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol. Sci. 88 (2005) 311-318
10. Glatt H., Schneider H., and Liu Y. V79-hCYP2E1-hSULT1A1, a cell line for the sensitive detection of genotoxic effects induced by carbohydrate pyrolysis products and other food-borne chemicals. Mutat. Res. 580 (2005) 41-52
11. Hasinoff B.B., Wu X., Krokhin O.V., Ens W., Standing K.G., Nitiss L., Sivaram T., Giorgianni A., Yang S., Jiang Y., and Yalowich J.C. Biochemical and proteomics approaches to characterize topoisomerase IIα cysteines and DNA as targets responsible for cisplatin-induced inhibition of topoisomerase IIα. Mol. Pharmacol. 67 (2005) 937-947
12. IARC (International Agency for Research on Cancer), 1994. IARC Monographs on the Evaluation of Carcinogen Risks to Humans: Some Industrial Chemicals. International Agency for Research on Cancer, Lyon, France 60, 389-433.
13. Jiang L., Cao J., An Y., Geng C., Qu S., Jiang L., and Zhong L. Genotoxicity of acrylamide in human hepatoma G2 (HepG2) cells. Toxicol. in Vitro 21 (2007) 1486-1492
14. Jensen L.H., Renodon-Corniere A., Wessel I., Langer S.W., Skilde B., Carstensen E.V., Sehested M., and Jensen P.B. Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition. Mol. Pharmacol. 61 (2002) 1235-1243
15. Jensen L.H., Thougaard A.V., Grauslund M., Søkilde B., Carstensen E.V., Dvinge H.K., Scudiero D.A., Jensen P.B., Shoemaker R.H., and Sehested M. Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors. Cancer Res. 65 (2005) 7470-7477
16. Jensen P.B., Sorensen B.S., Demant E.J., Sehested M., Jensen P.S., Vindelov L., and Hansen H.H. Antagonistic effect of aclarubicin on the cytotoxixity of etoposide and 4′-(9-acridinylamino) methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. Cancer Res. 50 (1990) 3311-3316
17. Kemplay S., and Cavanagh J.B. Effects of acrylamide and some other sulfhydryl reagents on spontaneous and pathologically induced terminal sprouting from motor end-plates. Muscle Nerve 7 (1984) 94-100
18. Martins C., Oliveira N.G., Pingarilho M., Gamboa da Costa G., Martins V., Marques M.M., Beland F.A., Churchwell M.I., Doerge D.R., Rueff J., and Gaspar J.F. Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts. Toxicol. Sci. 95 (2007) 383-390
19. Park J., Kamendulis L.M., Friedman M.A., and Klaunig J.E. Acrylamide-induced cellular transformation. Toxicol. Sci. 65 (2002) 177-183
20. Puppel N., Tjaden Z., Fuellear F., and Marko D. DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells. Mutat. Res. 580 (2005) 71-80
21. Rice J. The carcinogeneity of acrylamide. Mutat. Res. 580 (2005) 3-20
22. Sehested M., Wessel I., Jensen L.H., Holm B., Oliveri R.S., Kenwrick S., Creigthon A.M., Nitiss J.L., and Jensen P.B. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Cancer Res. 58 (1998) 1460-1468
23. Tareke E., Rydberg P., Karlsson P., Eriksson S., and Tomqvisti M. Analysis of acrylamide, a carcinogen formed in heated footstuffs. J. Agric. Food Chem. 50 (2002) 4998-5006
24. Tsuda H., Shimizu C.S., Taketomi M.K., Hasegawa M.M., Hamada A., Kawata K.M., and Inui N. Acrylamide: induction of DNA damage, chromosomal aberrations and cell transformation without gene mutations. Mutagenesis 8 (1993) 23-29
25. Wang H., Mao Y., Chen A.Y., Zhou N., LaVoie E.J., and Liu L.F. Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry 40 (2001) 3316-3323
26. Yang L., Rowe T.C., and Liu L.F. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells. Cancer Res. 45 (1985) 5872-5876
27. Zhang X., Cao J., Jiang L., Geng C., and Zhong L. Protective effect of hydroxytyrosol against acrylamide-induced cytotoxicity and DNA damage in HepG2 cells. Mutat. Res. 664 (2009) 64-68